Boehringer Ingelheim Snaps Up Lupin's MEK Inhibitor For Difficult-To-Treat Cancers

 
• By John Davis and Anju Ghangurde
Red signal
Cellular signaling pathway mutations are linked to cancer • Source: Shutterstock

More from Deals

More from Business